Zusammenfassung
Elektrolytstörungen sind häufig in der Intensivmedizin und können Mortalität und Morbidität beeinflussen. Eine rasche Diagnostik ist für eine adäquate Therapie notwendig, darf allerdings im Einzelfall nicht die notwendige Korrektur der Elektrolytstörung verzögern. Die Hyponatriämie mit schweren Symptomen wie Krampfanfällen oder Koma sollte in der Regel durch Gabe von 3 % NaCl behandelt werden, weniger klinisch ausgeprägte Formen sollten zunächst diagnostisch beurteilt und dann spezifisch behandelt werden. Die Hypernatriämie tritt insbesondere in der Intensivmedizin häufig auf und sollte in Abhängigkeit von der Genese therapiert werden, da die Hypernatriämie mit einer erhöhten Mortalität einhergeht. Hyperkaliämie und Hypokaliämie müssen insbesondere wegen Herzrhythmusstörungen rasch erkannt und therapiert werden. Während die Hypophosphatämie auf der Normalstation eine untergeordnete Rolle spielt, muss sie auf der Intensivstation diagnostiziert und substituiert werden, da hierdurch die Mortalität gesenkt werden kann.
Abstract
Electrolyte disorders frequently occur in intensive care medicine and can influence mortality and morbidity. A rapid diagnostic evaluation is required for adequate treatment but in individual cases, this should not delay the necessary correction of the electrolyte disorder. Hyponatremia with severe symptoms, such as seizures or coma usually requires the administration of 3% NaCl, while less clinically severe forms should initially be diagnostically assessed and then be specifically treated. Hypernatremia occurs particularly frequently in intensive care medicine and should be treated based on the genesis as hypernatremia is associated with increased mortality. Hyperkalemia and hypokalemia should be rapidly diagnosed and treated given the increased risk of cardiac arrhythmia. While hypophosphatemia plays a subordinate role on normal wards, on the intensive care unit it must be diagnosed and subsequently substituted as this can reduce mortality.
Literatur
Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E, Guideline Development Group (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 170:G1–G47
Brouns SHA, Dortmans MKJ, Jonkers FS, Lambooij SLE, Kuijper A, Haak HR (2014) Hyponatraemia in elderly emergency department patients: a marker of frailty. Neth J Med 72:311–317
Adrogué HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342:1581–1589. https://doi.org/10.1056/NEJM200005253422107
Turchin A, Seifter JL, Seely EW (2003) Clinical problem-solving. Mind the gap. N Engl J Med 349:1465–1469
Katz MA (1973) Hyperglycemia-induced hyponatremia—calculation of expected serum sodium depression. N Engl J Med 289:843–844
Sterns RH (2015) Disorders of plasma sodium. N Engl J Med 372:1269
Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH, Thompson CJ (2013) Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 126:S1–S42
Adrogué HJ, Madias NE (2000) Hypernatremia. N Engl J Med 342:1493–1499
Sterns RH, Silver SM (2003) Salt and water: read the package insert. QJM 96:549–552
Chauhan K, Pattharanitima P, Patel N, Duffy A, Saha A, Chaudhary K, Debnath N, Van Vleck T, Chan L, Nadkarni GN, Coca SG (2019) Rate of correction of hypernatremia and health outcomes in critically ill patients. Clin J Am Soc Nephrol 14:656–663
Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A (2018) Hypokalemia: a clinical update. Endocr Connect 7:R135–R146
McDonough AA, Youn JH (2017) Potassium homeostasis: the knowns, the unknowns, and the health benefits. Comp Biochem Physiol A Physiol 32:100–111
Gumz ML, Rabinowitz L, Wingo CS (2015) An integrated view of potassium homeostasis. N Engl J Med 373:60–72
Rengarajan S, Lee DH, Oh YT, Delpire E, Youn JH, McDonough AA (2014) Increasing plasma [K+] by intravenous potassium infusion reduces NCC phosphorylation and drives kaliuresis and natriuresis. Am J Physiol Renal Physiol 306:F1059–F1068
Huang C, Kuo E (2007) Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 18:2649–2652
Hougen I, Leon SJ, Whitlock R, Rigatto C, Komenda P, Bohm C, Tangri N (2021) Hyperkalemia and its association with mortality, cardiovascular events, hospitalizations, and intensive care unit admissions in a population-based retrospective cohort. Kidney Int Rep 6:1309–1316
Regolisti G, Maggiore U, Greco P, Maccari C, Parenti E, Di Mario F, Pistolesi V, Morabito S, Fiaccadori E (2020) Electrocardiographic T wave alterations and prediction of hyperkalemia in patients with acute kidney injury. Intern Emerg Med 15:463–472
Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR (2021) Clinical management of hyperkalemia. Mayo Clin Proc 96:744–762
Humphrey TJL, James G, Wilkinson IB, Hiemstra TF (2022) Clinical outcomes associated with the emergency treatment of hyperkalaemia with intravenous insulin-dextrose. Eur J Intern Med 95:87–92
Peacock WF, Rafique Z, Clark CL, Singer AJ, Turner S, Miller J, Char D, Lagina A, Smith LM, Blomkalns AL, Caterino JM, Kosiborod M, REVEAL-ED Study Investigators (2018) Real world evidence for treatment of Hyperkalemia in the emergency department (REVEAL-ED): a multicenter, prospective, observational study. J Emerg Med 55:741–750
Di Palo KE, Sinnett MJ, Goriacko P (2022) Assessment of patiromer monotherapy for Hyperkalemia in an acute care setting. JAMA Netw Open 5:e2145236
Toporek AH, Semler MW, Self WH, Bernard GR, Wang L, Siew ED, Stollings JL, Wanderer JP, Rice TW, Casey JD, SMART Investigators and the Pragmatic Critical Care Research Group (2021) Balanced crystalloids versus saline in critically ill adults with Hyperkalemia or acute kidney injury: secondary analysis of a clinical trial. Am J Respir Crit Care Med 203:1322–1325
Dhatariya KK, Joint British Diabetes Societies for Inpatient Care (2022) The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabet Med 39:e14788
Soliman HM, Mercan D, Lobo SSM, Mélot C, Vincent J (2003) Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med 31:1082–1087
Ryzen E, Elbaum N, Singer FR, Rude RK (1985) Parenteral magnesium tolerance testing in the evaluation of magnesium deficiency. Magnesium 4:137–147
Jiang P, Lv Q, Lai T, Xu F (2017) Does hypomagnesemia impact on the outcome of patients admitted to the intensive care unit? A systematic review and meta-analysis. Shock 47:288–295
Hansen B, Bruserud Ø (2018) Hypomagnesemia in critically ill patients. J Intensive Care 6:21. https://doi.org/10.1186/s40560-018-0291-y
RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638
da Silva JSV, Seres DS, Sabino K, Adams SC, Berdahl GJ, Citty SW, Cober MP, Evans DC, Greaves JR, Gura KM, Michalski A, Plogsted S, Sacks GS, Tucker AM, Worthington P, Walker RN, Ayers P, Parenteral Nutrition Safety and Clinical Practice Committees, American Society for Parenteral and Enteral Nutrition (2020) ASPEN consensus recommendations for Refeeding syndrome. Nutr Clin Pract 35:178–195
Doig GS, Simpson F, Heighes PT, Bellomo R, Chesher D, Caterson ID, Reade MC, Harrigan PWJ, Refeeding Syndrome Trial Investigators Group (2015) Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. Lancet Respir Med 3:943–952
Thompson Bastin ML, Stromberg AJ, Nerusu SN, Liu LJ, Mayer KP, Liu KD, Bagshaw SM, Wald R, Morris PE, Neyra JA (2022) Association of phosphate-containing versus phosphate-free solutions on ventilator days in patients requiring continuous kidney replacement therapy. Clin J Am Soc Nephrol 17:634–642
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Schenk, K.M. Schmidt-Ott und J.J. Schmidt geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
Thorsten Feldkamp, Rendsburg-Eckernförde
Oliver Witzke, Essen
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Schenk, H., Schmidt-Ott, K.M. & Schmidt, J.J. Elektrolytstörungen in der Intensivmedizin. Nephrologie 18, 7–13 (2023). https://doi.org/10.1007/s11560-022-00619-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11560-022-00619-1